Last updated on February 2020

A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis Who Have Failed Prior Biologic Therapy


Find a site near you

Start Over

Dr JP Wright /ID# 171138

Cape Town, South Africa
8.56miles
  Connect »

Mediclinic Constantiaberg /ID# 171137

Cape Town, South Africa
9.62miles
  Connect »